Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Cell adhesion inhibitor K-7174 exerts beneficial effects in murine model of Sjogren's syndrome

May 7, 2003

Roscovitine inhibits the proliferation of RPE cells

May 7, 2003

Porphyrin-based photosensitizers for use in ocular disorders, cancer, etc.

May 7, 2003

Approval and/or launch of major ophthalmic products reported by Allergan

May 5, 2003

Allergan and Acadia announce new drug discovery and development collaboration

May 5, 2003

ISV-403 moves into phase I clinical trials

May 5, 2003

Travatan indication extended for first-line therapy for ocular hypertension

May 2, 2003

Prous Science announces publication of state-of-the-art review: macular degeneration

April 30, 2003

IND filed for phase III bromfenac studies

April 28, 2003

EyeTech enters Xalatan commercialization agreement with Pfizer

April 24, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...